Quantifying fibrosis in inflammatory bowel diseases - contribution of digital pathology
Miha Jerala1, Li Chen2, David Drobne3
1Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
Background:
Fibrosis is a common characteristic of inflammatory bowel diseases (IBD), especially Crohn's disease (CD). Despite its significant contribution to disease morbidity, current histological methods for evaluating fibrosis in IBD lack standardization and suffer from poor reproducibility. Adding to the complexity, fibrosis varies across the different layers of the bowel wall.
Methods:
We applied a quantitative and phenotypic digital image analysis platform (FibroNest™) to whole slide images of IBD resection specimens stained with Masson trichrome to assess fibrosis and generate reproducible continuous scores for fibrosis severity. We also calculated four subscores based on different phenotypes of histological fibrosis to provide insights in the underlying differences of fibrosis in different bowel wall layers and disease states (CD with or without fibrostenosis and ulcerative colitis (UC)).
Results And Conclusions:
The generated scores showed a clear and significant separation of CD with fibrostenosis from CD without fibrostenosis and UC, while CD without fibrostenosis showed scores intermediate between UC and CD with fibrostenosis. We also devised a specific protocol to assess fibrosis in the mucosal layer, which has very little fibrosis but is accessible to endoscopic biopsies in contrast to the deeper layers. The mucosal protocol detected significant differences in fibrosis characteristics of the mucosa in CD with fibrosis and CD without fibrosis, which could possibly detect patients with underlying fibrostenosis before bowel resection.
More Related Videos
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
